In 1996 meningitis epidemic swept across Nigeria. Thousands of children were hit, and not having the appropriate medicine, tended to die from the disease. Doctors Pfizer was the antibiotic that can probably save most of their daily life. The product was new, however, and have not yet passed clinical trials with children. The company must decide whether to use the Nigerian outbreak as a platform for new and potentially risky tests. "Hide
by Adam Day, Debora L. Spar Source: Harvard Business School 19 pages. Publication Date: January 9, 2006. Prod. #: 706033-PDF-ENG
Related Case Solutions & Analyses:
Warner Bros. Entertainment
Managing a Global Team: Greg James at Sun Microsystems Inc. (B)
TRIPS Part II: International Trade meets Public Health: TRIPS and Access to Medicines Abridged
Property Rights in New Zealand Abalone Fisheries
India: The Dabhol Power Corporation (A)
ZMET Research Process
MOD Pizza: A Winning Recipe
REVOLUTION FOODS: EXPANSION INTO THE CPG MARKET
Firewall Vpn Solution Report
Exxonmobil Corporation
